Slate Path Capital LP's Form 4 filing
Korsana Biosciences, Inc.KRSA · filed Nov 25, 2024
- Accession no.
- 0000902664-24-006775
- Filed
- Nov 25, 2024, 4:05 PM ET
- Trade date
- Nov 21, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $555.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Slate Path Capital LPCIK 0001559706 | 10% Owner |
| Greenspan David GeraldCIK 0001820641 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | Common Stock, no par value | SSaleDisposed | −357,880 | $1.55 | −$555,107.67 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The Power of Attorney dated as of July 31, 2020 executed by David Greenspan authorizing Jim Feeney to sign and file this form on his behalf is attached as Exhibit 24.1 to the Reporting Persons Form 3 with respect to the Issuer filed with the Securities and Exchange Commission on August 10, 2020.